- Home
- PUMP vs ADPT Comparison
PUMP vs ADPT Comparison
Compare PUMP & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUMP
- ADPT
- Stock Information
- Founded
- PUMP 2007
- ADPT 2009
- Country
- PUMP United States
- ADPT United States
- Employees
- PUMP N/A
- ADPT N/A
- Industry
- PUMP Oilfield Services/Equipment
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PUMP Energy
- ADPT Health Care
- Exchange
- PUMP Nasdaq
- ADPT Nasdaq
- Market Cap
- PUMP 938.7M
- ADPT 929.8M
- IPO Year
- PUMP 2017
- ADPT 2019
- Fundamental
- Price
- PUMP $10.88
- ADPT $6.81
- Analyst Decision
- PUMP Buy
- ADPT Buy
- Analyst Count
- PUMP 7
- ADPT 4
- Target Price
- PUMP $11.17
- ADPT $6.75
- AVG Volume (30 Days)
- PUMP 1.9M
- ADPT 1.3M
- Earning Date
- PUMP 02-19-2025
- ADPT 02-12-2025
- Dividend Yield
- PUMP N/A
- ADPT N/A
- EPS Growth
- PUMP N/A
- ADPT N/A
- EPS
- PUMP N/A
- ADPT N/A
- Revenue
- PUMP $1,471,508,000.00
- ADPT $177,282,000.00
- Revenue This Year
- PUMP N/A
- ADPT $6.48
- Revenue Next Year
- PUMP N/A
- ADPT $18.72
- P/E Ratio
- PUMP N/A
- ADPT N/A
- Revenue Growth
- PUMP N/A
- ADPT N/A
- 52 Week Low
- PUMP $6.54
- ADPT $2.28
- 52 Week High
- PUMP $11.16
- ADPT $7.46
- Technical
- Relative Strength Index (RSI)
- PUMP 76.42
- ADPT 54.92
- Support Level
- PUMP $10.51
- ADPT $5.98
- Resistance Level
- PUMP $10.55
- ADPT $7.28
- Average True Range (ATR)
- PUMP 0.40
- ADPT 0.54
- MACD
- PUMP 0.10
- ADPT -0.00
- Stochastic Oscillator
- PUMP 87.11
- ADPT 58.06
About PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and coiled tubing.
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).